Ten-Year Follow up after Laparoscopic Nissen Fundoplication for Gastroesophageal Reflux Disease

Laparoscopic Nissen fundoplication was first undertaken in the early 1990s. Appreciable numbers of patients with 10-year follow up are only now available. This study assesses long-term outcome and durability of outcome after laparoscopic Nissen fundoplication for treatment of gastro-esophageal reflux disease. Since 1991, 829 patients have undergone laparoscopic fundoplications and are prospectively followed. Two hundred thirty-nine patients, 44 per cent male, with a median age of 53 years (± 15 standard deviation) underwent laparoscopic Nissen fundoplications at least 10 years ago; 28 (12%) patients were “redo” fundoplications. Before and after fundoplication, among many symptoms, patients scored the frequency and severity of dysphagia, chest pain, vomiting, regurgitation, choking, and heartburn using a Likert scale (0 = never/not bothersome to 10 = always/very bothersome). Symptom scores before versus after fundoplication were compared using a Wilcoxon matched-pairs test. Data are reported as median, mean ± standard deviation, when appropriate. After fundoplication, length of stay was 2 days, 3 days ± 4.8. Intra-operative inadvertent events were uncommon and without sequela: 1 esophagotomy, 1 gastrotomy, 3 cardiac dysrhythmias, and 3 CO2 pneumothoraces. Complications after fundoplication included: 1 postpneumonic empyema, 3 urinary retentions, 2 superficial wound infections, 1 urinary tract infection, 1 ileus, and 1 intraabdominal abscess. There were two perioperative deaths; 88 per cent of the patients are still alive. After laparoscopic Nissen fundoplication, frequency and severity scores dramatically improved for all symptoms queried (P < 0.001), especially for heartburn frequency (8, 8 ± 3.2 versus 2, 3 ± 2.8, P < 0.001) and severity (10, 8 ± 2.9 versus 1, 2 ± 2.5, P < 0.001). Eighty per cent of patients rate their symptoms as almost completely resolved or greatly improved, and 85 per cent note they would again have the laparoscopic fundoplication as a result of analysis of our initial experience, thereby promoting superior outcomes in the future. Nonetheless, follow up at 10 years and beyond of our initial experience documents that laparoscopic fundoplication durably provides high patient satisfaction resulting from long-term amelioration of the frequency and severity of symptoms of gastroesophageal reflux disease. These results promote further application of laparoscopic Nissen fundoplication.

[1]  T. Geagea Laparoscopic nissen’s fundoplication: preliminary report on ten cases , 2007, Surgical Endoscopy.

[2]  J. Birkmeyer,et al.  The rise and fall of antireflux surgery in the United States , 2006, Surgical Endoscopy.

[3]  D. Morgan,et al.  The Burden of Gastrointestinal and Liver Diseases, 2006 , 2006, The American Journal of Gastroenterology.

[4]  A. Madan,et al.  Emerging endoluminal therapies for gastroesophageal reflux disease: adverse events. , 2006, American journal of surgery.

[5]  M. Bloomston,et al.  Laparoscopic Nissen fundoplication offers High Patient Satisfaction with Relief of Extraesophageal Symptoms of Gastroesophageal Reflux Disease , 2006, The American surgeon.

[6]  P. Sedman,et al.  Laparoscopic fundoplication: A 10-year learning curve , 2006, Surgical Endoscopy And Other Interventional Techniques.

[7]  M. Bloomston,et al.  Esophagography predicts favorable outcomes after laparoscopic Nissen fundoplication for patients with esophageal dysmotility. , 2005, Journal of the American College of Surgeons.

[8]  P. Kahrilas,et al.  Endoluminal therapy for gastroesophageal reflux disease: Is the evidence for efficacy any stronger? , 2005, Current gastroenterology reports.

[9]  C. Wahlen,et al.  Clinical results of laparoscopic fundoplication at ten years after surgery , 2005, Surgical Endoscopy And Other Interventional Techniques.

[10]  J. Birkmeyer,et al.  National trends in utilization and outcomes of antireflux surgery , 2003, Surgical Endoscopy And Other Interventional Techniques.

[11]  R. Sampliner,et al.  Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. , 2001, JAMA.

[12]  J. Dent,et al.  Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. , 2000, Gastroenterology.

[13]  M. Bloomston,et al.  Quality of life and antireflux medication use following laparoscopic Nissen fundoplication. , 1998, The American surgeon.

[14]  A R Zinsmeister,et al.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. , 1997, Gastroenterology.

[15]  J. Peters,et al.  Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. , 1995 .

[16]  S. Spechler Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. , 1992, The New England journal of medicine.